메뉴 건너뛰기




Volumn 26, Issue 5, 2011, Pages 536-544

SB-742457 and donepezil in Alzheimer disease: A randomized, placebo-controlled study

Author keywords

5 HT6; Alzheimer's disease; Cognition; Global function; SB 742457; Serotonin

Indexed keywords

3 PHENYLSULFONYL 8 (1 PIPERAZINYL)QUINOLINE; DONEPEZIL; PLACEBO;

EID: 79953235869     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2562     Document Type: Article
Times cited : (93)

References (34)
  • 1
    • 0013163515 scopus 로고    scopus 로고
    • Woodcliff Lake, NJ. Eisai Co., Ltd
    • ARICEPT. [package insert]. Woodcliff Lake, NJ. Eisai Co., Ltd; 2006.
    • (2006) ARICEPT. [Package Insert]
  • 2
    • 40549106116 scopus 로고    scopus 로고
    • Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study (Journal of Alzheimer's Disease)
    • Bakchine S, Loft H. 2008. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study. Alzheimers Dis 13(1): 97-107. (Pubitemid 351365621)
    • (2008) Journal of Alzheimer's Disease , vol.13 , Issue.1 , pp. 97-107
    • Bakchine, S.1    Loft, H.2
  • 3
    • 42749100518 scopus 로고    scopus 로고
    • Cholinesterase inhibitors for Alzheimer's disease
    • Birks J. 2006. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 1: CD005593.
    • (2006) Cochrane Database Syst Rev , vol.1
    • Birks, J.1
  • 5
    • 46749120366 scopus 로고    scopus 로고
    • 5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease
    • Chuang ATT, Foley A, Pugh PL. 2006. 5-HT6 receptor antagonist SB-742457 as a novel cognitive enhancing agent for Alzheimer's disease. Alzheimer & Dementia 2: S631-S632.
    • (2006) Alzheimer & Dementia , vol.2
    • Chuang, A.T.T.1    Foley, A.2    Pugh, P.L.3
  • 7
    • 39749121622 scopus 로고    scopus 로고
    • The development of the Alzheimer's Carers' Quality of Life Instrument (ACQLI)
    • [Abstr 88]
    • Doward LC. 1997. The development of the Alzheimer's Carers' Quality of Life Instrument (ACQLI) [Abstr 88]. Qual of Life Res 6(suppl 7-8): 639.
    • (1997) Qual of Life Res , vol.6 , Issue.SUPPL. 7-8 , pp. 639
    • Doward, L.C.1
  • 8
    • 44149105604 scopus 로고    scopus 로고
    • The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats
    • Foley AG, Hirst WD, Gallagher HC, et al. 2008. The selective 5-HT6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats. Neuropharmacology 54(8): 1166-1174.
    • (2008) Neuropharmacology , vol.54 , Issue.8 , pp. 1166-1174
    • Foley, A.G.1    Hirst, W.D.2    Gallagher, H.C.3
  • 9
    • 0016823810 scopus 로고
    • Mini-mental state. A practical method for grading the cognitive state of patients for the clinician
    • Folstein MF, Folstein SE, McHugh PR. 1975. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-198.
    • (1975) J Psychiatr Res , vol.12 , Issue.3 , pp. 189-198
    • Folstein, M.F.1    Folstein, S.E.2    McHugh, P.R.3
  • 10
    • 36049013008 scopus 로고    scopus 로고
    • Polysialic acid-neural cell adhesion molecule in brain plasticity: From synapses to integration of new neurons
    • DOI 10.1016/j.brainresrev.2007.05.014, PII S0165017307000999
    • Gascon E, Vutskits L, Kiss JZ. 2007. Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons. Brain Res Rev 56(1): 101-118. (Pubitemid 350100865)
    • (2007) Brain Research Reviews , vol.56 , Issue.1 , pp. 101-118
    • Gascon, E.1    Vutskits, L.2    Kiss, J.Z.3
  • 11
    • 0033193134 scopus 로고    scopus 로고
    • Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia
    • Gélinas I, Gauthier L, McIntyre M, et al. 1999. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther 53: 471-481.
    • (1999) Am J Occup Ther , vol.53 , pp. 471-481
    • Gélinas, I.1    Gauthier, L.2    McIntyre, M.3
  • 16
    • 4444229993 scopus 로고    scopus 로고
    • Disease stage in Alzheimer disease and treatment effects of rivastigmine
    • DOI 10.1097/01.wad.0000127445.00442.a1
    • Kurz A, Farlow M, Quarg P, Spiegel R. 2004. Disease stage in Alzheimer disease and treatment effects of rivastigmine. Alzheimer Dis Assoc Disord 18(3): 123-128. (Pubitemid 39202187)
    • (2004) Alzheimer Disease and Associated Disorders , vol.18 , Issue.3 , pp. 123-128
    • Kurz, A.1    Farlow, M.2    Quarg, P.3    Spiegel, R.4
  • 17
    • 77957240989 scopus 로고    scopus 로고
    • Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease
    • Maher-Edwards G, Zvartau-Hind M, Hunter AJ, et al. 2010. Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease. Curr Alzheimer Res 7(5): 374-385.
    • (2010) Curr Alzheimer Res , vol.7 , Issue.5 , pp. 374-385
    • Maher-Edwards, G.1    Zvartau-Hind, M.2    Hunter, A.J.3
  • 18
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7): 939-944.
    • (1984) Neurology , vol.34 , Issue.7 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3
  • 19
    • 0035210592 scopus 로고    scopus 로고
    • 6 receptors in memory formation
    • Meneses A. 2001. Role of 5-HT6 receptors in memory formation. Drug News Perspect 14(7): 396-400. (Pubitemid 33140705)
    • (2001) Drug News and Perspectives , vol.14 , Issue.7 , pp. 396-400
    • Meneses, A.1
  • 20
    • 28044437798 scopus 로고    scopus 로고
    • 6 receptors: A novel target for cognitive enhancement
    • DOI 10.1016/j.pharmthera.2005.05.001, PII S0163725805000975
    • Mitchell ES, Neumaier JF. 2005. 5-HT6 receptors: a novel target for cognitive enhancement. Pharmacol Ther 108(3): 320-333. (Pubitemid 41691871)
    • (2005) Pharmacology and Therapeutics , vol.108 , Issue.3 , pp. 320-333
    • Mitchell, E.S.1    Neumaier, J.F.2
  • 22
    • 33745266146 scopus 로고    scopus 로고
    • Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
    • Risner ME, Saunders AM, Altman JF, et al. 2006. Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J 6(4): 246-254.
    • (2006) Pharmacogenomics J , vol.6 , Issue.4 , pp. 246-254
    • Risner, M.E.1    Saunders, A.M.2    Altman, J.F.3
  • 23
    • 0032507788 scopus 로고    scopus 로고
    • Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study
    • DOI 10.1001/archinte.158.9.1021
    • Rogers SL, Doody RS, Mohs RC, Friedhoff LT. 1998. Donepezil improves cognition and global function in Alzheimer's disease: A 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 158(9): 1021-1031. (Pubitemid 28213580)
    • (1998) Archives of Internal Medicine , vol.158 , Issue.9 , pp. 1021-1031
    • Rogers, S.L.1    Doody, R.S.2    Mohs, R.C.3    Friedhoff, L.T.4
  • 24
    • 0027534657 scopus 로고
    • Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
    • Roman GC, Tatemichi TK, Erkinjuntti T, et al. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43(2): 250-260.
    • (1993) Neurology , vol.43 , Issue.2 , pp. 250-260
    • Roman, G.C.1    Tatemichi, T.K.2    Erkinjuntti, T.3
  • 25
    • 0021520020 scopus 로고
    • A new rating scale for Alzheimer's disease
    • Rosen WG, Mohs RC, Davis KL. 1984. A new rating scale for Alzheimer's disease. Am J Psychiatr 141(11): 1356-1364.
    • (1984) Am J Psychiatr , vol.141 , Issue.11 , pp. 1356-1364
    • Rosen, W.G.1    Mohs, R.C.2    Davis, K.L.3
  • 26
    • 0033528436 scopus 로고    scopus 로고
    • Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial
    • Rösler M, Anand R, Cicin-Sain A, et al. 1999. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. Br Med J 318(7184): 633-638.
    • (1999) Br Med J , vol.318 , Issue.7184 , pp. 633-638
    • Rösler, M.1    Anand, R.2    Cicin-Sain, A.3
  • 27
    • 0030862602 scopus 로고    scopus 로고
    • Validity and reliability of the Alzheimer's Disease cooperative study-clinical global impression of change. The Alzheimer's Disease Cooperative Study
    • Schneider LS, Olin JT, Doody RS, et al. 1997. Validity and reliability of the Alzheimer's Disease cooperative study-clinical global impression of change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 11(Suppl 2): S22-S32.
    • (1997) Alzheimer Dis Assoc Disord , vol.11 , Issue.SUPPL. 2
    • Schneider, L.S.1    Olin, J.T.2    Doody, R.S.3
  • 28
    • 0034720864 scopus 로고    scopus 로고
    • A 5-month, randomized, placebo-controlled trial of galantamine in AD
    • Tariot PN, Solomon PR, Morris JC, et al. 2000. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 54(12): 2269-2276. (Pubitemid 30416277)
    • (2000) Neurology , vol.54 , Issue.12 , pp. 2269-2276
    • Tariot, P.N.1    Solomon, P.R.2    Morris, J.C.3    Kershaw, P.4    Lilienfeld, S.5    Ding, C.6
  • 30
    • 66349111984 scopus 로고    scopus 로고
    • Donepezil in the treatment of patients with Alzheimer's disease
    • Tsuno N. 2009. Donepezil in the treatment of patients with Alzheimer's disease. Expert Rev Neurother 9(5): 591-598.
    • (2009) Expert Rev Neurother , vol.9 , Issue.5 , pp. 591-598
    • Tsuno, N.1
  • 31
    • 46749118971 scopus 로고    scopus 로고
    • 6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease
    • DOI 10.1016/j.nurt.2008.05.008, PII S1933721308001001
    • Upton N, Chuang TT, Hunter AJ, Virley DJ. 2008. 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 5(3): 458-469. (Pubitemid 351952494)
    • (2008) Neurotherapeutics , vol.5 , Issue.3 , pp. 458-469
    • Upton, N.1    Chuang, T.T.2    Hunter, A.J.3    Virley, D.J.4
  • 32
    • 43249122280 scopus 로고    scopus 로고
    • Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: A randomised phase II trial
    • Wilcock GK, Black SE, Hendrix SB, et al. 2008. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial. Lancet Neurol 7(6): 483-493.
    • (2008) Lancet Neurol , vol.7 , Issue.6 , pp. 483-493
    • Wilcock, G.K.1    Black, S.E.2    Hendrix, S.B.3
  • 33
    • 0034627263 scopus 로고    scopus 로고
    • Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial
    • Galantamine International-1 Study Group
    • Wilcock GK, Lilienfeld S, Gaens E. Galantamine International-1 Study Group. 2000. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Br Med J 321(7274): 1445-1449.
    • (2000) Br Med J , vol.321 , Issue.7274 , pp. 1445-1449
    • Wilcock, G.K.1    Lilienfeld, S.2    Gaens, E.3
  • 34
    • 0026688466 scopus 로고
    • Alzheimer disease assessment scale: Useful for both early detection and staging of dementia of the Alzheimer type
    • Zec RF, Landreth ES, Vicari SK, et al. 1992. Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 6(2): 89-102.
    • (1992) Alzheimer Dis Assoc Disord , vol.6 , Issue.2 , pp. 89-102
    • Zec, R.F.1    Landreth, E.S.2    Vicari, S.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.